Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 16, Issue 3
|
pp. 2848–2865
Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology
Back to article
Figure 6
(6 of 8)
−
100%
+
Figure 6.
Molecular docking results of Hub protein and Erianin.
(
A
) Table of molecular docking results of Erianin and hub genes. (
B
–
G
) The molecular docking visualization results of Erianin binding to PPARA, ROCK2, PDGFRB, CCND1, MUC1 and CDK1.
